INVO BioScience, Inc. (IVOB)

Recent filings

INVO BioScience, Inc. director just picked up 2,339 shares - Dec. 1, 2020

INVO BioScience, Inc. director just picked up 1,137 shares - Dec. 1, 2020

INVO BioScience, Inc. director just picked up 2,317 shares - Dec. 1, 2020

Invo Bioscience And Idsmed Group Enter Distribution Agreement For Malaysia - Nov. 25, 2020

INVO BioScience, Inc. releases salary data. CEO sees compensation rise 0% - Nov. 20, 2020

As previously - Nov. 20, 2020

INVO BioScience, Inc. director just declared ownership of no shares of INVO BioScience, Inc. - Nov. 17, 2020

INVO BioScience, Inc. Just Filed Its Quarterly Report: Note 16 – Subsequen... - Nov. 16, 2020

INVO BioScience, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 13, 2020

Post-effective amendment adding exhibits to registration statement [Rule 462(d)] - Nov. 13, 2020

Invo Bioscience Announces Pricing Of Follow-On Public Offering And Listing On The Nasdaq Capital Market - Nov. 13, 2020

INVO BioScience, Inc. Just Received a Notice of Effectiveness - Nov. 12, 2020

Certification by an exchange approving securities for listing - Nov. 12, 2020

Registration of securities [Section 12(b)] - Nov. 12, 2020

Amendments to Articles of Incorporation or - Nov. 9, 2020

General form for registration of securities under the Securities Act of 1933 - Oct. 20, 2020

General form for registration of securities under the Securities Act of 1933 - Oct. 20, 2020

INVO BioScience, Inc. director just declared ownership of no shares of INVO BioScience, Inc. - Oct. 5, 2020

General form for registration of securities under the Securities Act of 1933 - Sept. 30, 2020

Invo Bioscience Establishes Joint Venture To Operate Dedicated Invocell Fertility Clinics In Mexico - Sept. 30, 2020

INVO BioScience, Inc. director just declared ownership of no shares of INVO BioScience, Inc. - Sept. 29, 2020

General form for registration of securities under the Securities Act of 1933 - Sept. 29, 2020

General form for registration of securities under the Securities Act of 1933 - Sept. 21, 2020

Election of - Sept. 16, 2020

INVO BioScience, Inc. Just Filed Its Quarterly Report: Note 15 – Subsequen... - Aug. 13, 2020

INVO BioScience, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 16, 2020

INVO BioScience, Inc. Just Received a Notice of Effectiveness - July 15, 2020

Notice of Exempt Offering of Securities, item 06b - July 15, 2020

General form for registration of securities under the Securities Act of 1933 - July 8, 2020

Entry into a Material Definitive - July 6, 2020

Entry into a Material Definitive - June 26, 2020

Notice of Exempt Offering of Securities, item 06b - May 28, 2020

Invo Bioscience Announces 1-For-20 Reverse Stock Split - May 22, 2020

INVO BioScience, Inc. Just Filed Its Quarterly Report: Note 15 – Subsequen... - May 15, 2020

Invo Bioscience Reports 2019 Financial Results - March 30, 2020

INVO BioScience, Inc. Just Filed Its Annual Report: Loss Per ShareBasic... - March 30, 2020

Invo Bioscience Changes Trading Symbol To “Invo” Effective March 16, 2020 - March 16, 2020

Our board of directors approved a change in our trading symbol from IVOB to - March 13, 2020

INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs - Feb. 13, 2020

INVO BioScience, Inc.'s Chief Executive Officer was just granted 99,112 options - Feb. 7, 2020

INVO BioScience, Inc.'s Medical Director was just granted 198,224 options and restricted shares - Feb. 7, 2020

INVO BioScience, Inc. director was just granted 99,112 options - Feb. 7, 2020

INVO BioScience, Inc. director was just granted 198,224 options and restricted shares - Feb. 7, 2020

INVO BioScience, Inc.'s Chief Operating Officer was just granted 99,112 options - Feb. 7, 2020

INVO Bioscience Receives IRB Approval to Begin Clinical Study Aimed at Expanded INVOcell Labeling - Feb. 5, 2020

Departure of Directors or Certain - Jan. 21, 2020

INVO Bioscience to Attend the 45th Edition of Arab Health Congress on January 27-30, 2020 - Jan. 21, 2020

INVO BioScience, Inc.'s Chief Operating Officer just picked up 1,000,000 shares - Jan. 21, 2020

Entry into a Material Definitive - Jan. 16, 2020

INVO BioScience, Inc. director just declared ownership of no shares of INVO BioScience, Inc. - Dec. 23, 2019

Departure of Directors or Certain - Dec. 19, 2019

KATHLEEN KARLOFF just provided an update on share ownership of INVO BioScience, Inc. - Dec. 11, 2019

ROBERT BOWDRING just provided an update on share ownership of INVO BioScience, Inc. - Dec. 11, 2019

INVO BioScience, Inc. releases salary data. CEO sees compensation rise 0% - Nov. 15, 2019

INVO BioScience, Inc. Just Filed Its Quarterly Report: Note 14 – Subsequen... - Nov. 14, 2019

INVO Bioscience Reports Third Quarter 2019 Financial Results - Nov. 14, 2019

INVO Bioscience Expands its Presence in Eurasia with New Distribution Agreements to Commercialize the INVOcell In Vivo Fertilization System - Nov. 12, 2019

INVO Bioscience Enters New Distribution Agreements in Africa to Commercialize the INVOcell In Vivo Fertilization System - Nov. 7, 2019

Other preliminary proxy statements - Nov. 5, 2019

INVOcell Pioneers, Center for Assisted Reproduction, Named One of the 10 Best Fertility Clinics for Innovation - Nov. 5, 2019

INVO Bioscience New CEO Sends Open Letter to Shareholders - Oct. 31, 2019

INVO BioScience, Inc. director was just granted 875,050 options - Oct. 31, 2019

INVO BioScience, Inc. director was just granted 962,336 options - Oct. 31, 2019

INVO BioScience, Inc.'s Chief Executive Officer just picked up 400,000 shares - Oct. 18, 2019

Securities to be offered to employees in employee benefit plans - Oct. 16, 2019

Departure of Directors or Principal - Oct. 15, 2019

INVO Bioscience to Exhibit at Two Upcoming Scientific and Research Conferences - Oct. 1, 2019

INVO BioScience, Inc.'s Acting CFO and PFO just declared ownership of no shares of INVO BioScience, Inc. - Sept. 30, 2019

INVO BioScience, Inc.'s Treasurer & Secretary just declared owning 11,715,942 shares of INVO BioScience, Inc. - Sept. 26, 2019

INVO BioScience, Inc. director just declared owning 600,000 shares of INVO BioScience, Inc. - Sept. 26, 2019

INVO BioScience, Inc.'s COO & VP Business Development just declared owning 607,800 shares of INVO BioScience, Inc. - Sept. 26, 2019

INVO BioScience, Inc.'s Medical Director just declared owning 5,073,197 shares of INVO BioScience, Inc. - Sept. 26, 2019

INVO BioScience, Inc.'s CEO & President just declared owning 14,200,183 shares of INVO BioScience, Inc. - Sept. 26, 2019

Changes in Registrants Certifying - Sept. 23, 2019

INVO BioScience, Inc. Just Received a Notice of Effectiveness - Sept. 16, 2019

General form for registration of securities under the Securities Act of 1933 - Sept. 9, 2019

Registration of securities [Section 12(g)] - Sept. 9, 2019

INVO Bioscience Reports Record Second Quarter 2019 Financial Results with Revenue Increasing 498% - Aug. 14, 2019

Quarterly report [Sections 13 or 15(d)] - Aug. 14, 2019

Invo Bioscience Reports Record Second Quarter 2019 Financial Results With Revenue Increasing 498% - Aug. 14, 2019

General form for registration of securities under the Securities Act of 1933 - July 29, 2019

INVO Bioscience Announces Recent Appointment of Pressly Ahammed as Director of International Business Development - June 19, 2019

INVO Bioscience's INVOcell Technology Featured in IVF Exhibit at the Science Museum in London - June 13, 2019

INVO BioScience: Item 10. Directors, Executive Officers And Corporate Governance - June 3, 2019

OTCQB Certification - May 17, 2019

INVO BioScience, Inc. Just Filed Its Quarterly Report: Note 14 – Subsequen... - May 15, 2019

INVO Bioscience Reports First Quarter 2019 Financial Results - May 15, 2019

INVO BioScience, Inc. Just Filed Its Annual Report: Loss Per ShareBasic... - April 16, 2019

INVO Bioscience Reports Record Fourth Quarter and Year End 2018 Financial Results - April 16, 2019

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - April 1, 2019

INVO Bioscience Appoints Michael J. Campbell as COO & VP of Business Development - Feb. 4, 2019

Major owner of INVO BioScience, Inc. just disposed of 678,826 shares - Feb. 1, 2019

Major owner of INVO BioScience, Inc. just disposed of 805,771 shares - Feb. 1, 2019

Invo Bioscience Closes Exclusive U.S. Licensing Agreement With Ferring Pharmaceuticals To Commercialize The Novel Invocell™ System For Use In The Treatment Of Infertility - Jan. 17, 2019

General form for registration of securities under the Securities Act of 1933 - Dec. 20, 2018

Major owner of INVO BioScience, Inc. just disposed of 1,500,000 shares - Dec. 3, 2018

INVO Bioscience to Present at the LD Micro Conference - Nov. 29, 2018

Fertility Partnership of St. Louis Expands Reproductive Services with the Introduction of INVOcell - Nov. 27, 2018

The Fertility Wellness Institute Becomes First Center in State of Ohio to Offer Revolutionary INVOcell Solution - Nov. 16, 2018

Invo Bioscience Enters Exclusive - Nov. 14, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Vantage Investment Advisors, LLC 59,970 N/A Sept. 30, 2018
 


Feedback